Is Spark Therapeutics’ Luxturna a Game Changer?
Shares of Spark Therapeutics saw a handy gain to close out the week after the FDA recommended approval of Luxturna.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 155
Are Analysts Secretly Calling Gilead a Screaming Buy?
Sometimes it turns out that great growth companies eventually run into the day when getting the growth of the past is not possible. That has been the case of Gilead Sciences since 2015.
Why Infinity Pharmaceuticals Shares Are Surging
Infinity Pharmaceuticals saw its shares almost double early on Thursday after the company announced good news.
Short Sellers Grow More Selective on Major Biotechs
The September 29 short interest data have been compared with the previous report, and short interest in the selected biotech stocks was mixed.
Short Sellers Run for Cover From Major Pharma
The September 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Why AnaptysBio Is One of Tuesday’s Top Stocks
AnaptysBio is easily one of the best performing stocks on Tuesday, with its shares jumping over 70% in this session.
KalVista Pharma Wins Big on Merck Collaboration
KalVista Pharmaceuticals saw its shares absolutely explode early on Tuesday after it was announced that the firm would be collaborating with Merck.
Even More Biopharma and FDA Catalysts Coming in October
24/7 Wall St. has collected a few more catalysts that are coming up in October for biotech and pharmaceutical companies.
4 Biotech Stocks to Buy That May See Huge Volatility From Earnings
Some of the top biotech stocks could become extremely volatile before and after earnings. These four that may be worth a look for aggressive investors.
Why ImmunoGen’s Secondary Makes Sense
ImmunoGen saw its shares make a sharp turn downward on Thursday morning after the stock has seen an incredible year of trading so far.
Why Exercise, Any Exercise, Is Beneficial to the Brain
Relatively modest changes in levels of exercise may have important public mental health benefits and prevent a substantial number of new cases of depression.
What CytomX Gets From Its Huge Amgen Collaboration
CytomX Therapeutics shares made a solid gain in Wednesday’s session following announcement of a strategic collaboration with Amgen in immuno-oncology.
Amicus Therapeutics Wins Big at World Muscle Society Conference
Amicus Therapeutics is another biotech player seeing a nice boost from the World Muscle Society Conference in France.
Why Catabasis Shares Are Surging
Catabasis Pharmaceuticals shares continued their incredible climb after the announcement of positive efficacy results from its MoveDMD trial in a late-breaking session at the World Muscle Society Conference in France.
Is This the Turnaround That Mylan Has Waited For?
Finally some good news out of Mylan, which potentially is bringing the shares back to about even for 2017.